Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A year after halting its ...
Ten months into 2025, and it’s clear the year hasn’t unfolded as many had expected—or hoped. Marked by a persistent bear market and compounded by geopolitical tensions and regulatory uncertainty, the ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
This article has been updated to correct the comparable weight loss and discontinuation rate for the Wegovy pill. Shares of Structure Therapeutics rallied 5.4% on Monday after the company said higher ...
Biotechnology has the potential to change the world. In the U.S., biotech jobs are vast and varied, but a select number of cities have become concentrated hot spots for companies leading innovation in ...
AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...
A biotech that lost federal funding Tuesday following Health Secretary Robert F. Kennedy Jr.’s edict that his agency’s pandemic preparedness division stop funding development of messenger RNA-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results